Angiotensin-Receptor Blockers for Prevention of Atrial Fibrillation - A Matter of Timing or Target?

被引：12

作者：

Gillis, Anne M. ^{[1
,2
]}

机构：

[1] Univ Calgary & Calgary Hlth Reg, Dept Cardiac Sci, Calgary, AB, Canada

[2] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 16期

关键词：

VALSARTAN; SYSTEM; TRIAL; HEART;

D O I：

10.1056/NEJMe0901602

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1669 / 1671

页数：3

共 12 条

[1] Prevention of Atrial Fibrillation Report From a National Heart, Lung, and Blood Institute Workshop [J].

Benjamin, Emelia J. ;

Chen, Peng-Sheng ;

Bild, Diane E. ;

Mascette, Alice M. ;

Albert, Christine M. ;

Alonso, Alvaro ;

Calkins, Hugh ;

Connolly, Stuart J. ;

Curtis, Anne B. ;

Darbar, Dawood ;

Ellinor, Patrick T. ;

Go, Alan S. ;

Goldschlager, Nora F. ;

Heckbert, Susan R. ;

Jalife, Jose ;

Kerr, Charles R. ;

Levy, Daniel ;

Lloyd-Jones, Donald M. ;

Massie, Barry M. ;

Nattel, Stanley ;

Olgin, Jeffrey E. ;

Packer, Douglas L. ;

Po, Sunny S. ;

Tsang, Teresa S. M. ;

Van Wagoner, David R. ;

Waldo, Albert L. ;

Wyse, D. George .

CIRCULATION, 2009, 119 (04) :606-618

[2] Structural and functional remodeling of the left atrium [J].

Casaclang-Verzosa, Grace ;

Gersh, Bernard J. ;

Tsang, Teresa S. M. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) :1-11

[3] Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence [J].

Disertori, Marcello ;

Latini, Roberto ;

Maggioni, Aldo Pietro ;

Delise, Pietro ;

Di Pasquale, Giuseppe ;

Franzosi, Maria Grazia ;

Staszewsky, Lidia ;

Tognoni, Gianni .

JOURNAL OF CARDIOVASCULAR MEDICINE, 2006, 7 (01) :29-38

[4]

Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710

[5] Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence [J].

Ehrlich, JR ;

Hohnloser, SH ;

Nattel, S .

EUROPEAN HEART JOURNAL, 2006, 27 (05) :512-518

[6] Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis [J].

Healey, JS ;

Baranchuk, A ;

Crystal, E ;

Morillo, CA ;

Garfinkle, M ;

Yusuf, S ;

Connolly, SJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) :1832-1839

[7]

Iravanian S, 2008, HEART RHYTHM, V5, P1499

[8] The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias [J].

Iravanian, Shahriar ;

Duley, SamueL C., Jr. .

HEART RHYTHM, 2008, 5 (06) :S12-S17

[9] Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study [J].

Madrid, AH ;

Bueno, MG ;

Rebollo, JMG ;

Marín, I ;

Peña, G ;

Bernal, E ;

Rodriguez, A ;

Cano, L ;

Cano, JM ;

Cabeza, P ;

Moro, C .

CIRCULATION, 2002, 106 (03) :331-336

[10] Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:: Results from the Valsartan Heart Failure Trial (Val-HeFT) [J].

Maggioni, AP ;

Latini, R ;

Carson, PE ;

Singh, SN ;

Barlera, S ;

Glazer, R ;

Masson, S ;

Cerè, E ;

Tognoni, G ;

Cohn, JN .

AMERICAN HEART JOURNAL, 2005, 149 (03) :548-557

← 1 2 →